Gh Research — A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N, N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers

6 slides

Gh Research · Health & Biotech · 2022

About this deck

Explore the presentation slide by slide for its financial analysis, transaction details, and investor communications.

Read moreRead less
Company
Gh Research
Industry
Health & Biotech
Year
2022
Slides
6
Company
Gh Research
Industry
Health & Biotech
Year
2022
Slides
6
Gh Research — A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N, N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers Investment Banking Pitch Deck | Banker Decks